Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Aug;70(2):371–375. doi: 10.1038/bjc.1994.308

Reduced bone mineral density in men following chemotherapy for Hodgkin's disease.

S J Holmes 1, R W Whitehouse 1, S T Clark 1, D C Crowther 1, J E Adams 1, S M Shalet 1
PMCID: PMC2033498  PMID: 8054287

Abstract

We have measured bone mineral density (BMD) in 29 men, mean age 35.0 (range 19.7-58.0) years, with testicular damage following MVPP or hybrid chemotherapy for Hodgkin's disease. Forearm cortical bone mineral content (BMC) and lumbar spine and femoral neck integral BMD were measured 3.4 (1.1-6.8) years after completion of chemotherapy, and results expressed as Z (standard deviation) scores. There was a significant reduction in forearm cortical BMC (median BMC 1.727 g cm-1, median Z-score -0.8, P < 0.0005), in lumbar spine integral BMD (median BMD 1.141 g cm-2, median Z-score -0.6, P < 0.0005) and in femoral neck integral BMD (median BMD 0.991 g cm-2, median Z-score -0.4, P < 0.05). There was no significant correlation between Z-score and time elapsed since completion of chemotherapy, and no significant difference in Z-score according to type of chemotherapeutic regimen or number of cycles of chemotherapy received. In conclusion, men who are in complete remission following treatment of Hodgkin's disease have reduced cortical and trabecular BMD. Possible causes include mild hypogonadism secondary to chemotherapy-induced impairment of Leydig cell function, a direct effect of chemotherapy on bone, an effect of high-dose glucocorticoid on bone or an effect of Hodgkin's disease per se.

Full text

PDF
371

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baylink D. J. Glucocorticoid-induced osteoporosis. N Engl J Med. 1983 Aug 4;309(5):306–308. doi: 10.1056/NEJM198308043090509. [DOI] [PubMed] [Google Scholar]
  2. Boddy K., King P. C., Hume R., Weyers E. The relation of total body potassium to height, weight, and age in normal adults. J Clin Pathol. 1972 Jun;25(6):512–517. doi: 10.1136/jcp.25.6.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cullum I. D., Ell P. J., Ryder J. P. X-ray dual-photon absorptiometry: a new method for the measurement of bone density. Br J Radiol. 1989 Jul;62(739):587–592. doi: 10.1259/0007-1285-62-739-587. [DOI] [PubMed] [Google Scholar]
  4. Cummings S. R., Black D. M., Nevitt M. C., Browner W., Cauley J., Ensrud K., Genant H. K., Palermo L., Scott J., Vogt T. M. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993 Jan 9;341(8837):72–75. doi: 10.1016/0140-6736(93)92555-8. [DOI] [PubMed] [Google Scholar]
  5. Finkelstein J. S., Klibanski A., Neer R. M., Doppelt S. H., Rosenthal D. I., Segre G. V., Crowley W. F., Jr Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1989 Oct;69(4):776–783. doi: 10.1210/jcem-69-4-776. [DOI] [PubMed] [Google Scholar]
  6. Finkelstein J. S., Klibanski A., Neer R. M., Greenspan S. L., Rosenthal D. I., Crowley W. F., Jr Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med. 1987 Mar;106(3):354–361. doi: 10.7326/0003-4819-106-3-. [DOI] [PubMed] [Google Scholar]
  7. Friedlaender G. E., Tross R. B., Doganis A. C., Kirkwood J. M., Baron R. Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am. 1984 Apr;66(4):602–607. [PubMed] [Google Scholar]
  8. Gotfredsen A., Jensen J., Borg J., Christiansen C. Measurement of lean body mass and total body fat using dual photon absorptiometry. Metabolism. 1986 Jan;35(1):88–93. doi: 10.1016/0026-0495(86)90101-0. [DOI] [PubMed] [Google Scholar]
  9. Greenspan S. L., Neer R. M., Ridgway E. C., Klibanski A. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med. 1986 Jun;104(6):777–782. doi: 10.7326/0003-4819-104-6-777. [DOI] [PubMed] [Google Scholar]
  10. Horowitz M., Wishart J. M., O'Loughlin P. D., Morris H. A., Need A. G., Nordin B. E. Osteoporosis and Klinefelter's syndrome. Clin Endocrinol (Oxf) 1992 Jan;36(1):113–118. doi: 10.1111/j.1365-2265.1992.tb02910.x. [DOI] [PubMed] [Google Scholar]
  11. Kassirer J. R. Clinical problem-solving--a new feature in the Journal. N Engl J Med. 1992 Jan 2;326(1):60–61. doi: 10.1056/NEJM199201023260112. [DOI] [PubMed] [Google Scholar]
  12. Kreuser E. D., Felsenberg D., Behles C., Seibt-Jung H., Mielcarek M., Diehl V., Dahmen E., Thiel E. Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease. Ann Oncol. 1992 Sep;3 (Suppl 4):105–110. doi: 10.1093/annonc/3.suppl_4.s105. [DOI] [PubMed] [Google Scholar]
  13. Laskey M. A., Crisp A. J., Cole T. J., Compston J. E. Comparison of the effect of different reference data on Lunar DPX and Hologic QDR-1000 dual-energy X-ray absorptiometers. Br J Radiol. 1992 Dec;65(780):1124–1129. doi: 10.1259/0007-1285-65-780-1124. [DOI] [PubMed] [Google Scholar]
  14. Redman J. R., Bajorunas D. R., Wong G., McDermott K., Gnecco C., Schneider R., Lacher M. J., Lane J. M. Bone mineralization in women following successful treatment of Hodgkin's disease. Am J Med. 1988 Jul;85(1):65–72. doi: 10.1016/0002-9343(88)90504-9. [DOI] [PubMed] [Google Scholar]
  15. Stepán J. J., Lachman M., Zverina J., Pacovský V., Baylink D. J. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab. 1989 Sep;69(3):523–527. doi: 10.1210/jcem-69-3-523. [DOI] [PubMed] [Google Scholar]
  16. Thomsen K., Gotfredsen A., Christiansen C. Is postmenopausal bone loss an age-related phenomenon? Calcif Tissue Int. 1986 Sep;39(3):123–127. doi: 10.1007/BF02555106. [DOI] [PubMed] [Google Scholar]
  17. Tsatsoulis A., Whitehead E., St John J., Shalet S. M., Robertson W. R. The pituitary-Leydig cell axis in men with severe damage to the germinal epithelium. Clin Endocrinol (Oxf) 1987 Dec;27(6):683–689. doi: 10.1111/j.1365-2265.1987.tb02952.x. [DOI] [PubMed] [Google Scholar]
  18. Wahner H. W., Riggs B. L., Beabout J. W. Diagnosis of osteoporosis: usefulness of photon absorptiometry at the radius. J Nucl Med. 1977 May;18(5):432–437. [PubMed] [Google Scholar]
  19. Whitehead E., Shalet S. M., Blackledge G., Todd I., Crowther D., Beardwell C. G. The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male. Cancer. 1982 Feb 1;49(3):418–422. doi: 10.1002/1097-0142(19820201)49:3<418::aid-cncr2820490304>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES